Goods and bads of the endocannabinoid system as a therapeutic target: Lessons learned after 30 years

M Maccarrone, V Di Marzo, J Gertsch, U Grether… - Pharmacological …, 2023 - ASPET
The cannabis derivative marijuana is the most widely used recreational drug in the Western
world and is consumed by an estimated 83 million individuals (∼ 3% of the world …

[HTML][HTML] Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities

ED Mock, B Gagestein, M van der Stelt - Progress in Lipid Research, 2023 - Elsevier
Abstract N-acylethanolamines (NAEs), including N-palmitoylethanolamine (PEA), N-
oleoylethanolamine (OEA), N-arachidonoylethanolamine (AEA, anandamide), N …

Enhancement of peripheral fatty acyl ethanolamide signaling prevents stress-induced social avoidance and anxiety-like behaviors in male rats

L Carnevali, M Barbetti, Y Fotio, F Ferlenghi… - …, 2023 - Springer
Rationale Exposure to traumatic events can lead to alterations in social and anxiety-related
behaviors. Emerging evidence suggests that peripheral host-defense processes are …

Fatty acid amide hydrolase inhibition alleviates anxiety-like symptoms in a rat model used to study post-traumatic stress disorder

Y Fotio, A Mabou Tagne, KM Jung, D Piomelli - Psychopharmacology, 2023 - Springer
Background and aim Post-traumatic stress disorder (PTSD), a chronic debilitating condition
that affects nearly 5–10% of American adults, is treated with a handful of FDA-approved …

[HTML][HTML] Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain

S Nobili, L Micheli, E Lucarini, A Toti… - Pharmacology & …, 2024 - Elsevier
Current epidemiological data estimate that one in five people suffers from chronic pain with
considerable impairment of health-related quality of life. The pharmacological treatment is …

Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory

L Zhou, M Tian, B Zhang, X Cao, X Huo, F Yang… - International Journal of …, 2024 - Elsevier
N-acylethanolamine acid amidase (NAAA) is a nucleophilic lysosomal cysteine hydrolase,
which primarily mediates the hydrolytic inactivation of endogenous palmitoylethanolamide …

α-Acylamino-β-lactone N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors Encapsulated in PLGA Nanoparticles: Improvement of the Physical Stability and …

A Gagliardi, R Molinaro, M Fresta, A Duranti, D Cosco - Antioxidants, 2022 - mdpi.com
N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase that
preferentially catalyzes the hydrolysis of endogenous lipid mediators such as …

NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice

Y Fotio, A Mabou Tagne, E Squire, H Lee… - Nature …, 2024 - nature.com
Circulating monocytes participate in pain chronification but the molecular events that cause
their deployment are unclear. Using a mouse model of hyperalgesic priming (HP), we show …

Genetic blockade of NAAA cell-specifically regulates fatty acid ethanolamides (FAEs) metabolism and inflammatory responses

X Xie, Y Li, S Xu, P Zhou, L Yang, Y Xu, Y Qiu… - Frontiers in …, 2022 - frontiersin.org
N-Acylethanolamine acid amidase (NAAA) is a lysosomal enzyme responsible for the
hydrolysis of fatty acid ethanolamides (FAEs). However, the role of NAAA in FAEs …

Δ9-Tetrahydrocannabinol alleviates hyperalgesia in a humanized mouse model of sickle cell disease

AM Tagne, Y Fotio, K Gupta… - … of Pharmacology and …, 2024 - jpet.aspetjournals.org
People with sickle cell disease (SCD) often experience chronic pain as well as
unpredictable episodes of acute pain, which significantly affects their quality of life and life …